文献速递介入胸部外周血管MRDSA

经皮淋巴管栓塞治疗Gorham-Stout病继发乳糜胸

Percutaneous Lymphatic Embolization for Chylothorax Secondary to Gorham-Stout Disease.
PubMed 文献 · Korean J Radiol · 2025-01-01

回顾性单中心研究纳入5例Gorham-Stout病继发乳糜胸或血性乳糜胸患者,行经皮淋巴管栓塞。关键影像表现为巨大胸导管(3例)和壁层胸膜淋巴管扩张(5例)。仅胸导管栓塞临床成功率25%(1/4),加行壁层胸膜淋巴管及其他侧支栓塞后达80%(4/5)。

要点

  • GSD相关乳糜胸术前应评估胸导管及壁层胸膜淋巴管,巨大胸导管和壁层胸膜淋巴管扩张为关键表现。
  • 仅胸导管栓塞临床成功率25%(1/4),联合壁层胸膜淋巴管及侧支栓塞后达80%(4/5)。
  • 1例患者胸导管栓塞后出现乳糜性腹水。

核心结论

  • 针对胸导管和胸膜淋巴管侧支的经皮淋巴管栓塞是GSD相关乳糜胸可行的治疗选择。

研究设计与样本

  • 回顾性单中心研究,纳入2013年1月至2022年12月连续接受经皮淋巴管栓塞的患者5例(男性,年龄5-29岁),术前行动态对比增强MR淋巴管造影和/或透视下结内淋巴管造影评估淋巴解剖,根据影像表现行胸导管栓塞、胸膜淋巴管栓塞或两者联合。

关键影像表现/征象

  • 巨大胸导管3例。
  • 壁层胸膜淋巴管系统扩张5例。
  • 乳糜胸3例,血性乳糜胸2例。

诊断标准与关键数值

  • 临床成功定义为拔除引流管后无积液再积聚或临床症状改善。
  • 仅胸导管栓塞临床成功1/4(25%)。
  • 加行壁层胸膜淋巴管及其他侧支栓塞后临床成功4/5(80%)。

临床应用与阅片要点

  • 术前应评估胸导管及壁层胸膜淋巴管,巨大胸导管和壁层胸膜淋巴管扩张为关键影像表现。
  • 根据影像表现选择胸导管栓塞、胸膜淋巴管栓塞或两者联合。
  • 共行12次栓塞(中位2次/例,范围1-4次);栓塞结构包括胸导管4例、壁层胸膜淋巴管4例、其他淋巴侧支3例;栓塞剂为胶加弹簧圈3例、单用胶2例。

局限性

  • 回顾性单中心研究。
  • 样本量小(5例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the role and treatment response of percutaneous lymphatic embolization performed for non-traumatic chylothorax in patients with Gorham-Stout disease (GSD) with regard to thoracic duct embolization (TDE) and embolization of pleural or lymphatic collaterals.

MATERIALS AND METHODS: This retrospective single-institution study included consecutive patients who underwent percutaneous lymphatic embolization between January 2013 and December 2022. The patients underwent dynamic contrast-enhanced magnetic resonance lymphangiography, fluoroscopic intranodal lymphangiography, or both to evaluate the lymphatic anatomy prior to the intervention. The patients underwent TDE, pleural lymphatic embolization, or both, depending on the imaging findings. The data collected included imaging findings, procedural details, and clinical outcomes (clinical success was defined as removal of the drainage catheter without re-accumulation of effusion or improvement in clinical symptoms).

RESULTS: Five male patients (aged 5-29 years) with chylothorax (n = 3) or hemorrhagic chylothorax (n = 2) were included. The key imaging findings included giant thoracic duct (n = 3) and dilated parietal pleural lymphatic system (n = 5). Twelve embolization sessions were performed (median, 2 sessions per patient; range 1-4 sessions). The embolized lymphatic structures included the thoracic duct (n = 4), parietal pleural lymphatics (n = 4), and other lymphatic collaterals (n = 3). The embolic agents used were glue and coils (n = 3), and glue only (n = 2). TDE alone achieved clinical success in only 25% of the cases (1 out of 4). With additional embolization of the parietal pleural lymphatics and other collaterals, clinical success was achieved in 80% of the cases (4 out of 5). One patient developed chylous ascites after the TDE.

CONCLUSION: Percutaneous lymphatic embolization targeting the thoracic duct and pleural lymphatic collaterals is a feasible treatment option for GSD-related chylothorax.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Lim DY, Hur S, Moon HE, et al. Percutaneous Lymphatic Embolization for Chylothorax Secondary to Gorham-Stout Disease. Korean J Radiol. 2025. PMID: 41015859. doi:10.3348/kjr.2025.0264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。